BIB ETF

$81.97

Returns Overview

1 Month
-5.81%
3 Months
-6.17%
6 Months
+2.69%
YTD
+2.94%
1 Year
+51.14%
3 Years
+11.52%
5 Years
-2.50%
10 Years
+6.89%

Risk Metrics (1-Year)

No risk data available for this ETF

Stress Test Scenarios

How would BIB have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

-5.81%

3 Months Performance

-6.17%

6 Months Performance

+2.69%

1 Year Performance

+51.14%

Benchmark & Peers

Benchmark
NASDAQ Biotechnology Index(^NBI)
This ETF (YTD)
+2.94%
Peer Avg (YTD)
-1.20%
vs Peers
+4.13%

BIB ETF Performance

BIB performance across multiple time periods: 1-month -5.81%, YTD 2.94%, 1-year 51.14%, 3-year 11.52%, 5-year -2.50%, 10-year 6.89%.

BIB returns outperform the peer average of -1.20% YTD. With an expense ratio of 0.95%, investors should weigh costs against performance when evaluating this ETF.

BIB performance comparison shows side-by-side returns with another fund. BIB alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month-5.81%Apr 22, 2026 to May 22, 2026
3 Months-6.17%Feb 23, 2026 to May 22, 2026
6 Months+2.69%Nov 24, 2025 to May 22, 2026
1 Year+51.14%N/A
3 Years+11.52%N/A
5 Years-2.50%N/A

All returns shown are total returns, not annualized